Gail Cherry-Peppers, Cheryl Fryer, Andrea D Jackson, Xinbin Gu, Debra Ford, Alison Glascoe, Dawn Smith, Meirong Liu, Jacquelyn Dunmore-Griffith, Gillian Robinson-Warner, Crystal McIntosh, Jezelle Sonnier, Lisa Slade, Adel Rizkalla, Shakeya Mundey, Nyree Dawson, Manouchka Fleurinord, Baron Edmonson, Courtney Ford, Jillian Griffith, Gretchen Peppers, Kavya Muttanahally, Fatima Mncube-Barnes, Terri Watkins-Bryant
{"title":"Sickle cell disease: Contributing factors and radiological assessments.","authors":"Gail Cherry-Peppers, Cheryl Fryer, Andrea D Jackson, Xinbin Gu, Debra Ford, Alison Glascoe, Dawn Smith, Meirong Liu, Jacquelyn Dunmore-Griffith, Gillian Robinson-Warner, Crystal McIntosh, Jezelle Sonnier, Lisa Slade, Adel Rizkalla, Shakeya Mundey, Nyree Dawson, Manouchka Fleurinord, Baron Edmonson, Courtney Ford, Jillian Griffith, Gretchen Peppers, Kavya Muttanahally, Fatima Mncube-Barnes, Terri Watkins-Bryant","doi":"10.1016/j.jnma.2023.05.004","DOIUrl":"10.1016/j.jnma.2023.05.004","url":null,"abstract":"<p><p>Sickle Cell Disease (SCD) is genetically described as an autosomal blood disorder resulting from the presence of a mutated form of hemoglobin. Morbidity, frequency of crisis, degree of anemia, and organ systems involved vary considerably per patient. Dental health professionals and other specialists commonly request comprehensive medical consultations prior to performing complex periodontal, endodontic, and surgical procedures. In order to have successful dental outcomes and minimize posttreatment dental complications, relevant disease indicators are noted. This review is to raise awareness of the impact of oral diseases in patients with sickle cell disease and to emphasize the importance of full medical disclosure, radiographic interpretation, and a well-documented medical history, and a well-written consultation which can guide treatment planning and greatly improve the course of dental treatment.</p>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":" ","pages":"636-641"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9876556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heba Hussein, Adel Rizkalla, Jezelle Sonnier, Ronald S Brown
{"title":"Sialadenitis of the anterior mandibular vestibule: A subset of burning mouth syndrome.","authors":"Heba Hussein, Adel Rizkalla, Jezelle Sonnier, Ronald S Brown","doi":"10.1016/j.jnma.2023.07.001","DOIUrl":"10.1016/j.jnma.2023.07.001","url":null,"abstract":"<p><p>Burning Mouth syndrome (BMS) is a relatively common oral neurosensory disorder known for oral burning pain. In that there is a relative absence of oral clinical findings and systemic causation, the diagnosis of BMS is challenging. Sialadenitis of the anterior mandibular vestibule appears to be a subset of BMS. The lip component of chronic orofacial pain is potentially an important concern with regard to the diagnosis and treatment of chronic orofacial pain. Discussion regarding the etiology, diagnosis, and therapy of this condition is provided.</p>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":" ","pages":"642-645"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9924931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lp(a) and risk of cardiovascular disease – A review of existing evidence and emerging concepts","authors":"Manasa Jasti , Sabrina Islam , Nathan Steele , Kendra Ivy , Willibroad Maimo , Ijeoma Isiadinso","doi":"10.1016/j.jnma.2023.11.009","DOIUrl":"10.1016/j.jnma.2023.11.009","url":null,"abstract":"<div><div><span>Cardiovascular disease (CVD) remains the leading cause of death among adults in the United States. There has been significant advancement in the diagnosis and treatment of atherosclerotic cardiovascular disease<span> (ASCVD) and its underlying risk factors. In certain populations, there remains a significant residual risk despite adequate lowering of low-density lipoprotein cholesterol (LDL-C) and control of traditional risk factors. This has led to an interest in research to identify additional risk factors that contribute to atherosclerotic cardiovascular disease. Elevated lipoprotein (a) [Lp(a)] has been identified as an independent risk factor contributing to an increased risk for CVD. There are also ethnic and </span></span>racial disparities<span> in Lp(a) inheritance that need to be understood. This paper reviews the current literature on lipoprotein a, proposed mechanisms of actions for cardiovascular disease, recommendations for testing, and the current and emerging therapies for lowering Lp(a).</span></div></div>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 508-516"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The beacon of hope program: Co-creating effective, measurable solutions for health equity","authors":"Priscilla Pemu , Celia Maxwell , Rajbir Singh , Jaydutt Vadgama , Shahanaz Arjumand , Linda Armstrong","doi":"10.1016/j.jnma.2024.09.002","DOIUrl":"10.1016/j.jnma.2024.09.002","url":null,"abstract":"","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 566-568"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amie A. Ogunsakin , Tomilola I. Olakunde , Moses D. Fehintola , Ifeoluwa Malmberg , Akinwale Olakunde , Ayotunde O. Dokun
{"title":"Updates in pharmacotherapy of obesity","authors":"Amie A. Ogunsakin , Tomilola I. Olakunde , Moses D. Fehintola , Ifeoluwa Malmberg , Akinwale Olakunde , Ayotunde O. Dokun","doi":"10.1016/j.jnma.2024.09.004","DOIUrl":"10.1016/j.jnma.2024.09.004","url":null,"abstract":"<div><div>Obesity is now recognized as a chronic, progressive condition requiring early intervention and long-term management to achieve health benefits and improve metabolic risk factors. The main objective of obesity pharmacotherapy is weight loss and weight loss maintenance. There is increasing acceptance of anti-obesity medications as an adjunct to lifestyle modifications and/or surgery. In recent years there has been an evolution in management approach and pharmacologic options for treatment. As a result, there is increased focus on the efficacy and safety of these agents. We provide a historical perspective, review of recent studies on anti-obesity medication outcomes showing efficacy, potential side effects and promising therapies in development.</div></div>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 576-587"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing hypertension in African Americans with heart failure: A guide for the primary care clinician","authors":"Bria Rice , Lydia Mbatidde , Oludamilola Oluleye , Anekwe Onwuanyi , Demilade Adedinsewo","doi":"10.1016/j.jnma.2023.11.004","DOIUrl":"10.1016/j.jnma.2023.11.004","url":null,"abstract":"<div><div>Hypertension is the predominant risk factor for cardiovascular disease related morbidity and mortality among Black adults in the United States. It contributes significantly to the development of heart failure and increases the risk of death following heart failure diagnosis. It is also a leading predisposing factor for hypertensive disorders of pregnancy and peripartum cardiomyopathy<span> in Black women. As such, all stakeholders including health care providers, particularly primary care clinicians (including physicians and advanced practice providers), patients, and communities must be aware of the consequences of uncontrolled hypertension among Black adults. Appropriate treatment strategies should be identified and implemented to ensure timely and effective blood pressure management among Black individuals, particularly those with, and at risk for heart failure.</span></div></div>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 477-489"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138505058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie L. Borum MD, EdD, MPH, MACP, FACG, AGAF, FRCP (Editor-In-Chief, Journal of the National Medical Association)
{"title":"Special Issue on Cardiovascular Health in African-Americans and More","authors":"Marie L. Borum MD, EdD, MPH, MACP, FACG, AGAF, FRCP (Editor-In-Chief, Journal of the National Medical Association)","doi":"10.1016/j.jnma.2024.10.004","DOIUrl":"10.1016/j.jnma.2024.10.004","url":null,"abstract":"","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Page 465"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JaNae’ Richard , Jacob Sama , Anekwe Onwuanyi , Onyedika J. Ilonze
{"title":"Top five considerations for improving outcomes in black patients with heart failure: A guide for primary care clinicians","authors":"JaNae’ Richard , Jacob Sama , Anekwe Onwuanyi , Onyedika J. Ilonze","doi":"10.1016/j.jnma.2023.11.008","DOIUrl":"10.1016/j.jnma.2023.11.008","url":null,"abstract":"<div><div>Black patients develop heart failure at younger ages and have worse outcomes such as higher mortality rates compared to other racial and ethnic groups in the United States. Despite significant recent improvements in heart failure medical therapy, these worse outcomes have persisted. Multiple reasons have been provided to explain the situation, including but not limited to higher baseline cluster of cardiovascular risk factors amongst Black patients, inadequate use of heart failure guideline directed medical therapy and delayed referral for advanced heart failure therapies and interventions. Strategic interventions considering social and structural determinants of health, addressing structural inequalities/ bias, implementation of quality improvement programs, early diagnosis and prevention are critically needed to bridge the racial/ ethnic disparities gap and improve longevity of Black patients with heart failure. In this review, we propose evidence-based solutions that provide a framework for the primary care physician addressing these challenges to engender equity in treatment allocation and improve outcomes for all patients with heart failure.</div></div>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 499-507"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138541409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hakeem Ayinde , Favour Markson , Ugonna Kevin Ogbenna , Larry Jackson II
{"title":"Addressing racial differences in the management of atrial fibrillation: Focus on black patients","authors":"Hakeem Ayinde , Favour Markson , Ugonna Kevin Ogbenna , Larry Jackson II","doi":"10.1016/j.jnma.2023.11.007","DOIUrl":"10.1016/j.jnma.2023.11.007","url":null,"abstract":"<div><div>Atrial fibrillation<span> (AF) is the most common sustained arrhythmia<span>, affecting between 3 and 6 million people in the United States. It is associated with a reduced quality of life and increased risk of stroke, cognitive decline, heart failure and death. Black patients have a lower prevalence of AF than White patients but are more likely to suffer worse outcomes with the disease. It is important that stakeholders understand the disproportionate burden of disease and management gaps that exists among Black patients living with AF. Appropriate treatments, including aggressive risk factor control, early referral to cardiovascular specialists and improving healthcare access may bridge some of the gaps in management and improve outcomes.</span></span></div></div>","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 490-498"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138541445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Leonidas H. Berry Health Equity Research Award - ACG Announcement","authors":"","doi":"10.1016/j.jnma.2024.10.011","DOIUrl":"10.1016/j.jnma.2024.10.011","url":null,"abstract":"","PeriodicalId":17369,"journal":{"name":"Journal of the National Medical Association","volume":"116 5","pages":"Pages 626-631"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}